190 related articles for article (PubMed ID: 15387447)
21. Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the Emergency Department: comparison with brain natriuretic peptide (BNP).
Chenevier-Gobeaux C; Claessens YE; Voyer S; Desmoulins D; Ekindjian OG
Clin Chim Acta; 2005 Nov; 361(1-2):167-75. PubMed ID: 15993397
[TBL] [Abstract][Full Text] [Related]
22. [Factors associated plasma B type natriuretic peptide and N-terminal pro-B-type natriuretic peptide levels].
Chen Y; Yao CL; Shimada T
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Sep; 36(9):825-30. PubMed ID: 19102867
[TBL] [Abstract][Full Text] [Related]
23. Biochemistry of B-type natriuretic peptide--where are we now?
Mair J
Clin Chem Lab Med; 2008; 46(11):1507-14. PubMed ID: 18842106
[TBL] [Abstract][Full Text] [Related]
24. B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.
Bal L; Thierry S; Brocas E; Van de Louw A; Pottecher J; Hours S; Moreau MH; Perrin Gachadoat D; Tenaillon A
Acta Anaesthesiol Scand; 2006 Mar; 50(3):340-7. PubMed ID: 16480468
[TBL] [Abstract][Full Text] [Related]
25. Amino-terminal proBNP in ovine plasma: evidence for enhanced secretion in response to cardiac overload.
Pemberton CJ; Yandle TG; Rademaker MT; Charles CJ; Aitken GD; Espiner EA
Am J Physiol; 1998 Oct; 275(4):H1200-8. PubMed ID: 9746467
[TBL] [Abstract][Full Text] [Related]
26. Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease.
Mueller T; Gegenhuber A; Poelz W; Haltmayer M
Clin Chim Acta; 2004 Mar; 341(1-2):41-8. PubMed ID: 14967157
[TBL] [Abstract][Full Text] [Related]
27. N-terminal pro-B-type natriuretic peptide in patients with isolated traumatic brain injury: a prospective cohort study.
Wu X; Sha H; Sun Y; Gao L; Liu H; Yuan Q; Zhang T; Zhu J; Zhou L; Hu J
J Trauma; 2011 Oct; 71(4):820-5; discussion 825. PubMed ID: 21808206
[TBL] [Abstract][Full Text] [Related]
28. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.
Luchner A; Hengstenberg C; Löwel H; Riegger GA; Schunkert H; Holmer S
Hypertension; 2005 Jul; 46(1):118-23. PubMed ID: 15939804
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic accuracy of plasma brain natriuretic peptide and aminoterminal-proBNP in mild heart failure depends on assay and introduction of therapy.
Mikkelsen KV; Bie P; Møller JE; Ryde H; Videbaek L; Haghfelt T
Scand J Clin Lab Invest; 2005; 65(8):633-47. PubMed ID: 16319038
[TBL] [Abstract][Full Text] [Related]
30. Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides.
Ala-Kopsala M; Ruskoaho H; Leppäluoto J; Seres L; Skoumal R; Toth M; Horkay F; Vuolteenaho O
Clin Chem; 2005 Apr; 51(4):708-18. PubMed ID: 15718490
[TBL] [Abstract][Full Text] [Related]
31. PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay.
Zaninotto M; Mion MM; Di Serio F; Caputo M; Ottomano C; Plebani M
Clin Chem Lab Med; 2010 Jul; 48(7):1029-34. PubMed ID: 20406130
[TBL] [Abstract][Full Text] [Related]
32. Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship.
Takase H; Dohi Y
Eur J Clin Invest; 2014; 44(3):303-8. PubMed ID: 24372567
[TBL] [Abstract][Full Text] [Related]
33. Predictors of increased cumulative serum levels of the N-terminal prohormone of brain natriuretic peptide 4 days after acute spontaneous subarachnoid hemorrhage.
Nyberg C; Karlsson T; Ronne-Engström E
J Neurosurg; 2014 Mar; 120(3):599-604. PubMed ID: 24093631
[TBL] [Abstract][Full Text] [Related]
34. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
[TBL] [Abstract][Full Text] [Related]
35. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.
Farombi-Oghuvbu I; Matthews T; Mayne PD; Guerin H; Corcoran JD
Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F257-60. PubMed ID: 18218660
[TBL] [Abstract][Full Text] [Related]
36. Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure.
Miller WL; Hartman KA; Burritt MF; Borgeson DD; Burnett JC; Jaffe AS
Clin Chem; 2005 Mar; 51(3):569-77. PubMed ID: 15615816
[TBL] [Abstract][Full Text] [Related]
37. The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure.
Seferian KR; Tamm NN; Semenov AG; Mukharyamova KS; Tolstaya AA; Koshkina EV; Kara AN; Krasnoselsky MI; Apple FS; Esakova TV; Filatov VL; Katrukha AG
Clin Chem; 2007 May; 53(5):866-73. PubMed ID: 17384012
[TBL] [Abstract][Full Text] [Related]
38. Comparison of brain natriuretic peptide and probrain natriuretic peptide in the diagnosis of cardiogenic pulmonary edema in patients aged 65 and older.
Ray P; Arthaud M; Birolleau S; Isnard R; Lefort Y; Boddaert J; Riou B
J Am Geriatr Soc; 2005 Apr; 53(4):643-8. PubMed ID: 15817011
[TBL] [Abstract][Full Text] [Related]
39. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload.
Pemberton CJ; Johnson ML; Yandle TG; Espiner EA
Hypertension; 2000 Sep; 36(3):355-9. PubMed ID: 10988264
[TBL] [Abstract][Full Text] [Related]
40. Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt-proBNP) in the elderly.
Alehagen U; Goetze JP; Dahlström U
Clin Chim Acta; 2007 Jul; 382(1-2):8-14. PubMed ID: 17433809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
